Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 2,358 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $16,175.88. Following the transaction, the insider now owns 4,174 shares of the company's stock, valued at approximately $28,633.64. The trade was a 36.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Fernando M. Rodrigues also recently made the following trade(s):
- On Tuesday, June 3rd, Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock. The shares were sold at an average price of $6.91, for a total value of $28,842.34.
Teladoc Health Trading Down 2.7%
Shares of Teladoc Health stock traded down $0.20 on Thursday, hitting $6.93. 5,451,781 shares of the company traded hands, compared to its average volume of 6,260,843. The stock's 50 day moving average price is $7.18 and its 200-day moving average price is $9.16. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The company has a market cap of $1.21 billion, a PE ratio of -1.20 and a beta of 1.82.
Analyst Ratings Changes
Several research analysts recently commented on TDOC shares. Canaccord Genuity Group dropped their price target on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Bank of America dropped their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Piper Sandler dropped their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Stifel Nicolaus dropped their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Finally, Evercore ISI dropped their price target on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a research report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $9.60.
Read Our Latest Report on TDOC
Institutional Trading of Teladoc Health
Several institutional investors and hedge funds have recently modified their holdings of the stock. Arizona State Retirement System raised its stake in shares of Teladoc Health by 1.8% during the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock valued at $452,000 after acquiring an additional 859 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its holdings in Teladoc Health by 9.6% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock valued at $113,000 after buying an additional 1,089 shares during the period. Canada Pension Plan Investment Board lifted its holdings in Teladoc Health by 0.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock worth $2,079,000 after buying an additional 1,200 shares during the period. Summit Investment Advisors Inc. lifted its holdings in Teladoc Health by 8.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock worth $164,000 after buying an additional 1,331 shares during the period. Finally, Vise Technologies Inc. lifted its holdings in Teladoc Health by 4.9% during the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after buying an additional 1,405 shares during the period. Institutional investors own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories

Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.